Ebvia is a privately held biotechnology firm working on innovative outpatient treatment for COVID-19 infections. In a highly deadly animal model, the medication candidate showed survival against SARS-COV-2 infection compared to the control group. In mice infected with the SARS-COV-2 virus, it also reduced lung and brain damage. The candidate iseffective against the delta variant and has shown potent efficacy against various influenza strains in animal models.

Biotechnology

Ebvia

Org chart

Similar companies